Stem Cell–Derived Islets Continue to Show Benefit in T1D ...Middle East

Medscape - News
In the latest update of Vertex's VX-880, three patients at high hypoglycemia risk achieved A1c < 7% with no severe hypoglycemia episodes and were insulin independent at 1 year. Medscape Medical News

Hence then, the article about stem cell derived islets continue to show benefit in t1d was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Stem Cell–Derived Islets Continue to Show Benefit in T1D )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News